Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-administration of CoronaVac Booster with Influenza and Pneumococcal Vaccines
NCT05499351Phase 4Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Oct 2021
- Primary completion
- Dec 2021
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of coronavac in coronavirus disease 2019 (COVID-19), influenza, Pneumococcal pneumonia (PP), sponsored by Sinovac Biotech Ltd.. Started Oct 2021; status: completed.
02
Drugs
coronavac
03
Conditions
coronavirus disease 2019 (COVID-19)influenzaPneumococcal pneumonia (PP)
Beyond the preview
Go deeper on NCT05499351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05499351.